What changed
$TT — AVOID 📊 | 6 MONTHS THESIS
🎯 Q1 2026 | EPS $2.63 vs $2.53 🟢
💡 The Q1 EPS beat ($2.63 vs. $2.53) and guidance raise signal accelerating growth, but consensus already expects robust performance. The small beat and rich valuation imply the gap is narrow: the market may be underestimating near-term momentum, but any slowdown would hit the stock hard.
📉 Reward/risk: 1.5:1
🏢 Business Quality: 8/10
📊 Valuation: rich — trailing P/E ~46x vs. sector median ~20x and 5-year average ~30x. Even on forward estimates, multiples remain elevated. EV/EBITDA likely >25x.
🔮 Catalyst: Q2 2026 earnings report (expected late July / early August)
💰 Entry: $483.15, stop $459.0, target $520.0
⚖️ Avoid initiating new long positions at current elevated valuation despite strong fundamentals; wait for a pullback or clearer catalyst.
📊 Our read: AVOID. Full analysis →
https://stockduty.xyz/s/TT0625